STABLE ORAL ANTIRETROVIRAL TREATMENT FOR AT LEAST 6 MONTHS

Clinical trials for STABLE ORAL ANTIRETROVIRAL TREATMENT FOR AT LEAST 6 MONTHS explained in plain language.

Never miss a new study

Get alerted when new STABLE ORAL ANTIRETROVIRAL TREATMENT FOR AT LEAST 6 MONTHS trials appear

Sign up with your email to follow new studies for STABLE ORAL ANTIRETROVIRAL TREATMENT FOR AT LEAST 6 MONTHS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New HIV shot combo aims to replace daily pills

Disease control Terminated

This study planned to test a two-drug injectable treatment (cabotegravir and lenacapavir) for people with HIV who have tried many medications. The goal was to see if the shots could keep the virus under control without needing daily pills. However, the study was withdrawn before …

Matched conditions: STABLE ORAL ANTIRETROVIRAL TREATMENT FOR AT LEAST 6 MONTHS

Phase: PHASE2 • Sponsor: Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba • Aim: Disease control

Last updated May 17, 2026 08:15 UTC

STABLE ORAL ANTIRETROVIRAL TREATMENT FOR AT LEAST 6 MONTHS

Get alerted when new STABLE ORAL ANTIRETROVIRAL TREATMENT FOR AT LEAST 6 MONTHS trials appear

New HIV shot combo aims to replace daily pills